跳至主要内容
临床试验/NCT01382641
NCT01382641Unknown4 期

Relevance of Eye Dominance in the Selection of Patients Suitable for Treatment With Monovision After Cataract Surgery

Innovative Medical1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
4 期
入组人数
20
试验地点
1
主要终点
Measuring Ocular Dominance

研究概览

简要总结

The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must desire to pursue some type of mono-vision fit, mono-vision lasik, or mono-vision cataract surgery with lens implant.
  • Patients must be candidates for intraocular lens implantation for the correction of aphakia following extracapsular cataract extraction by phaco-emulsification.
  • Patients must be candidates for bilateral implantation and desiring post-operative spectacle independence through targeted mono-vision.
  • Patients must have less than 1.50 diopters of corneal astigmatism
  • Patients must have the potential for best corrected visual acuity of 20/30 or better in each eye.
  • Patients must have the mental capacity to cooperate when undergoing a detailed postoperative refractive examination.
  • Patients must be an adult.
  • Patients must provide written informed consent for cataract surgery.
  • Patients must be willing and able to return for scheduled follow-up examinations for a period of 3 months (post-second eye) post-operatively.
  • Patients must be willing and able to provide feedback to various survey questions regarding overall satisfaction and ease of adaptation to mono-vision and range of vision, etc.

排除标准

  • Patients with 1.50 diopters or more of corneal astigmatism
  • Patients requiring a lens power less than 6 D or greater than 30 D
  • Patients with any anterior segment pathology (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, corneal dystrophy or corneal degeneration, tear film deficiency, poor pupil dilation, etc.).
  • Patients with uncontrolled glaucoma or who require current treatment for glaucoma, or with visual field loss as a result of glaucoma.
  • Patients with retinal pathology or a history of retinal detachment.
  • Patients with proliferative diabetic retinopathy, macular degeneration, or other degenerative visual disorders.
  • Patients with a history of previous ocular surgery including corneal refractive surgery.
  • Patients with congenital bilateral cataracts.
  • Patients with marked microphthalmos or aniridia.
  • Patients who have only one functioning eye.
  • Patients who do not have the potential for visual acuity of 20/30 or better in each eye.
  • Patients lacking intact binocular vision.
  • Patients who do not have an intact capsulorhexis and posterior capsular bag at the time of cataract removal and lens implantation.
  • Patients who have incomplete or damaged zonules, or who have zonular rupture during cataract removal.
  • Patients with pupils greater than 7mm

结局指标

主要结局

Measuring Ocular Dominance

时间窗: 3 months

Overall post surgical outcomes

时间窗: 3 months

次要结局

  • Measuring visual acuities(3 months)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验